Merck Recalls Entire Supply of Cholesterol Drug Liptruzet
Merck & Co. announced Tuesday that it is recalling the entire U.S. stock of the combination cholesterol drug Liputruzet citing defects that could reduce effectiveness.
About the Liptruzet Recall
- According to ABC, the recall affects every batch of Liptruzet since it original launch date last May.
- Liptruzet, which is available in four dose strengths, combines two common cholesterol drugs which work together to reduce levels of LDL with the overall goal of reducing a patient’s risk of suffering a heart attack and stroke.
- The company stated that some of the foil pouches that hold the pills may allow air and moisture inside, potentially decreasing the drug’s effectiveness and/or changing its properties.
Side Effects of Liptruzet
Aside from the recall, the following adverse events have been linked to Liptruzet use:
- Respiratory tract infection
- Necrotizing myopathy
- Tendon rupture
- Hepatic failure
- Hypersensitive reactions
- Stevens-Johnson syndrome
- Toxic epidermal necrolysis
Contact an Experienced Drug Recall Attorney
Thomas J. Henry are leaders in the area of drug and product liability litigation. Our Defective Drug and Products Division have extensive knowledge and resources in order to represent our clients efficiently and aggressively. The Defective Drug and Products Division represent a multitude of people who are battling against manufacturers of medical devices and/or defective pharmaceuticals.
If you or a loved one have been injured by or have developed serious side-effects from the use of recalled medications or pharmaceuticals, contact Thomas J. Henry immediately. We represent clients/victims all over the country. We are available 24/7, nights and weekends.